The broad kinase selectivity of these PTK6 inhibitors is not known, therefore it is not certain whether the observed inhibitory effects on tumor cells is due to the specific inhibition of PTK6 kinase and/or an off-target effect by affecting other kinases. This evidence concerns the gene PTK6 and neoplasm.